Learn about membership types and categories.
Leadership
- Eligibility for appointment as HCI Program Leader (Type 1)
- Eligibility for appointment as HCI Translational Scholar (Type 1)
- Eligibility for inclusion in HCI strategic planning (Type 1, 2)
- Opportunity to provide input on Program and Shared Resource development (Type 1, 2)
Institutional Funding Opportunities
- Program Funding
- Pilot Research
- Type 1 and Type 2 members are eligible to serve as PIs or co-investigators
- Early-Stage Investigators (as defined by NIH) may serve as PIs, but must include a mentoring component
- Travel funding (Type 1, 2)
- Pilot Research
- Center for Investigational Therapeutics (CIT)
- Project Funding (Type 1, 2)
- Team Science Acceleration (TSA) Funding
- Pilot Research
- Type 1 and Type 2 members are eligible to serve as PIs or co-investigators
- Pilot Research
- Translational Science Initiative (TSI) Funding
- Pilot Research
- Type 1 and Type 2 members are eligible to serve as PIs or co-investigators
- Early-Stage Investigators (as defined by NIH) may serve as PIs, but must include a mentoring component
- Pilot Research
- Eligibility to apply for NCI Cancer Center Support Grant (CCSG) Supplement funding (Type 1, 2)
- Eligibility to apply for American Cancer Society (ACS) Institutional Research Seed Grants (Type 2)
- Eligibility to apply for HCI-managed limited submission extramural funding opportunities (All)
Information and Community
- Receipt of information regarding external funding opportunities (All)
- Receipt of the HCI newsletter; direct notification of Cancer Center seminars and activities (All)
- Opportunities to interact with cancer research-oriented colleagues via HCI retreats, symposia, seminars, and meetings (All)
- Designation as an HCI Investigator (All)
Scientific and Administrative Support
- Access to HCI-managed Shared Resources (All)
- Access to interventional clinical research support (All)
Membership Responsibilities
All members are expected to:
- Participate in Cancer Center activities, such as collaborative research projects and/or clinical trials, meetings, seminars, and retreats
- Respond to requests for information on research progress, ‘other support pages’, publications, extramural funding, trainees, and biosketches with timely and accurate submissions
- Acknowledge the Cancer Center Support Grant in publications where appropriate
- Grant HCI Administration access to funding information provided by PeopleSoft Management Reports
Comprehensive Cancer Center Director
Comprehensive Cancer Center Deputy Director
Senior Directors
Neeraj Agarwal, MD
Clinical Research
Donald Ayer, PhD
Co-Director, Cancer Research Training and Education Coordination
Rachel Ceballos, PhD
Community Outreach and Engagement
Max Loveless, MBA
Senior Administrative Director
Martin McMahon, PhD
Preclinical Translation
Tracy Onega, PhD, MS
Population Sciences
Gita Suneja, MD, MS
Programs to Enhance Diversity
Aik Choon Tan, PhD
Data Science
Katharine Ullman, PhD
Co-Director, Cancer Research Training and Education Coordination
Alana Welm, PhD
Basic Science
David Wetter, PhD, MS
Cancer Health Equity Science
Program Leadership
Nuclear Control of Cell Growth and Differentiation
Jay Gertz, PhD
Co-Leader
Jared Rutter, PhD
Co-Leader
Cell Response and Regulation
Shannon Buckley
Co-Leader
Sheri Holmen, PhD
Co-Leader
Experimental Therapeutics
Howard Colman, MD, PhD
Co-Leader
Martin McMahon, PhD
Co-Leader
Cancer Control and Population Sciences
Jennifer Doherty, MS, PhD
Co-Leader
Kimberly Kaphingst, ScD
Co-Leader
Kathleen Mooney, PhD
Co-Leader